398 related articles for article (PubMed ID: 25295252)
1. The role of microRNAs in ovarian cancer.
Kinose Y; Sawada K; Nakamura K; Kimura T
Biomed Res Int; 2014; 2014():249393. PubMed ID: 25295252
[TBL] [Abstract][Full Text] [Related]
2. microRNA and Ovarian Cancer.
Langhe R
Adv Exp Med Biol; 2015; 889():119-51. PubMed ID: 26659000
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in ovarian cancer biology and therapy resistance.
van Jaarsveld MT; Helleman J; Berns EM; Wiemer EA
Int J Biochem Cell Biol; 2010 Aug; 42(8):1282-90. PubMed ID: 20083225
[TBL] [Abstract][Full Text] [Related]
4. miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.
Shi C; Zhang Z
Tumour Biol; 2016 Apr; 37(4):5437-43. PubMed ID: 26563371
[TBL] [Abstract][Full Text] [Related]
5. miR-215 functions as a tumor suppressor in epithelial ovarian cancer through regulation of the X-chromosome-linked inhibitor of apoptosis.
Ge G; Zhang W; Niu L; Yan Y; Ren Y; Zou Y
Oncol Rep; 2016 Mar; 35(3):1816-22. PubMed ID: 26676658
[TBL] [Abstract][Full Text] [Related]
6. The emerging roles and therapeutic potential of microRNAs (miRs) in liposarcoma.
Sun R; Shen JK; Choy E; Yu Z; Hornicek FJ; Duan Z
Discov Med; 2015 Nov; 20(111):311-24. PubMed ID: 26645903
[TBL] [Abstract][Full Text] [Related]
7. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer.
Biamonte F; Santamaria G; Sacco A; Perrone FM; Di Cello A; Battaglia AM; Salatino A; Di Vito A; Aversa I; Venturella R; Zullo F; Costanzo F
Sci Rep; 2019 Apr; 9(1):5668. PubMed ID: 30952937
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review).
Palma Flores C; García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Astudillo de la Vega H; Marchat LA; Salinas Vera YM; López-Camarillo C
Int J Oncol; 2017 May; 50(5):1461-1476. PubMed ID: 28393213
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.
Gao YC; Wu J
Tumour Biol; 2015 Jun; 36(6):4843-50. PubMed ID: 25636451
[TBL] [Abstract][Full Text] [Related]
11. Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.
Zhou J; Gong G; Tan H; Dai F; Zhu X; Chen Y; Wang J; Liu Y; Chen P; Wu X; Wen J
Oncol Rep; 2015 Jun; 33(6):2915-23. PubMed ID: 25962395
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.
Staicu CE; Predescu DV; Rusu CM; Radu BM; Cretoiu D; Suciu N; Crețoiu SM; Voinea SC
Cells; 2020 Jan; 9(1):. PubMed ID: 31936634
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
15. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer.
Huh JH; Kim TH; Kim K; Song JA; Jung YJ; Jeong JY; Lee MJ; Kim YK; Lee DH; An HJ
Br J Cancer; 2013 Jul; 109(2):452-61. PubMed ID: 23807165
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma.
Braga EA; Loginov VI; Filippova EA; Burdennyi AM; Pronina IV; Kazubskaya TP; Khodyrev DS; Utkin DO; Kushlinskii DN; Adamyan LV; Kuslinskii NE
Bull Exp Biol Med; 2018 Dec; 166(2):253-256. PubMed ID: 30488208
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targeting of miRNA-216b in cancer.
Jana S; Krishna M; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
Cancer Lett; 2020 Aug; 484():16-28. PubMed ID: 32387443
[TBL] [Abstract][Full Text] [Related]
19. Let-7 expression defines two differentiation stages of cancer.
Shell S; Park SM; Radjabi AR; Schickel R; Kistner EO; Jewell DA; Feig C; Lengyel E; Peter ME
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11400-5. PubMed ID: 17600087
[TBL] [Abstract][Full Text] [Related]
20. miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.
Muys BR; Sousa JF; Plaça JR; de Araújo LF; Sarshad AA; Anastasakis DG; Wang X; Li XL; de Molfetta GA; Ramão A; Lal A; Vidal DO; Hafner M; Silva WA
Cancer Res; 2019 Jul; 79(13):3294-3305. PubMed ID: 31101765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
